Comparison of msp genotyping and a 24 SNP molecular assay for differentiating Plasmodium falciparum recrudescence from reinfection

Abstract Background Current World Health Organization guidelines for conducting anti-malarial drug efficacy clinical trials recommend genotyping Plasmodium falciparum genes msp1 and msp2 to distinguish recrudescence from reinfection. A more recently developed potential alternative to this method is...

Descripció completa

Dades bibliogràfiques

Autors principals:	Joseph Fulakeza, Sarah McNitt, Jimmy Vareta, Alex Saidi, Godfrey Mvula, Terrie Taylor, Don P. Mathanga, Dylan S. Small, Jacek Skarbinski, Julie R. Gutman, Karl Seydel
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2019-03-01
Col·lecció:	Malaria Journal
Matèries:	Malaria Plasmodium falciparum msp genotyping 24 SNP genotyping Reinfection Recrudescence
Accés en línia:	http://link.springer.com/article/10.1186/s12936-019-2695-0
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!